Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**Financial Risk Summary: Tatva Chintan Pharma Chem Limited** Tatva Chintan faces maximum exposure to **compliance risk (10.0/10)**, with estimated remediation costs of ₹1–2 crore linked to incomplete BRSR disclosures and uncertain Extended Producer Responsibility (EPR) applicability—a critical gap given SEBI's enforcement priority for top-tier listed companies. The company's missing Scope 1 and 2 emissions data creates dual vulnerability: inability to quantify carbon liability under India's nascent carbon credit trading scheme (₹600–900/tonne), and non-compliance with mandatory BRSR P6 environmental disclosures, risking SEBI enforcement action or potential delisting for a ₹366.4 crore revenue entity. Water intensity (5.0/10) and GHG intensity (5.0/10) remain unquantified, blocking proactive cost management; the undefined EPR status (6.5/10) exposes the company to retrospective liability if chemical waste regulations tighten. Immediate priority: complete Scope
Source: Tatva Chintan Pharma Chem Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.